So, I think it’s a good time to buy SNY ahead of earnings. Sanofi (NASDAQ:SNY) is quickly becoming one of the largest biopharma companies across immunology, oncology, rare disease treatments ...

Also Read: Sanofi’s Blood Cancer Drug’s New Subcutaneous Formulation Hits Primary Goal In Late-Stage In Multiple Myeloma The facility’s quality unit was also scrutinized for its inability to ...

The long-awaited fight between Terence Crawfordand Canelo Alvarez is getting closer and closer to becoming a reality. Undisputed super middleweight champion Canelo has turned up the heat on the ...

French pharmaceutical giant Sanofi has received a warning letter from the U.S. Food and Drug Administration following an inspection at its drug manufacturing facility in Framingham. French ...

Julian Alvarez scored twice to guide Atleti to a comeback win over Bayer Leverkusen in the Champions League. Getty Images "It's a game that will be remembered by the people that saw it," Simeone ...

Julian Alvarez scored a second-half brace as a 10-man Atletico Madrid came from a goal down to beat Bayer Leverkusen 2-1 at home on Tuesday, and take a major step towards a top-eight finish.

Canelo Alvarez's new rivalry with Terence Crawford has heated up as he questioned his potential opponent's professional record. Alvarez and Crawford are two of the sport's current pound-for-pound ...

Sanofi’s (NASDAQ:SNY) consumer healthcare unit Opella announced Tuesday that the U.S. FDA has lifted a clinical hold on a trial designed to test an over-the-counter version of its erectile ...

Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a U.S. drug ingredients plant tied to its longstanding subsidiary Genzyme.

In 2014, Lilly inked a licensing agreement with Sanofi that allows the latter company to pursue regulatory approval of OTC Cialis in the U.S., Europe, Canada and Australia.

(RTTNews) - Sanofi's Consumer Healthcare division, Opella, announced that the U.S. Food and Drug Administration has lifted a clinical hold on its planned actual use trial (AUT). The trial is aimed ...

The Food and Drug Administration has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility in Massachusetts where the company makes ...